Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Total Liabilities: 2019-2025

Historic Total Liabilities for Revolution Medicines (RVMD) over the last 7 years, with Sep 2025 value amounting to $655.0 million.

  • Revolution Medicines' Total Liabilities rose 233.01% to $655.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $655.0 million, marking a year-over-year increase of 233.01%. This contributed to the annual value of $293.1 million for FY2024, which is 24.45% up from last year.
  • Per Revolution Medicines' latest filing, its Total Liabilities stood at $655.0 million for Q3 2025, which was up 16.10% from $564.2 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Total Liabilities peaked at $655.0 million during Q3 2025, and registered a low of $89.0 million during Q2 2021.
  • In the last 3 years, Revolution Medicines' Total Liabilities had a median value of $196.7 million in 2024 and averaged $274.1 million.
  • In the last 5 years, Revolution Medicines' Total Liabilities declined by 8.16% in 2023 and then surged by 233.01% in 2025.
  • Over the past 5 years, Revolution Medicines' Total Liabilities (Quarterly) stood at $135.4 million in 2021, then fell by 6.41% to $126.7 million in 2022, then soared by 85.82% to $235.5 million in 2023, then grew by 24.45% to $293.1 million in 2024, then skyrocketed by 233.01% to $655.0 million in 2025.
  • Its Total Liabilities was $655.0 million in Q3 2025, compared to $564.2 million in Q2 2025 and $287.2 million in Q1 2025.